Results 31 to 40 of about 769 (173)

Effect of Excisional Goniotomy with the Kahook Dual Blade (KDB) on Surgically Induced Astigmatism. [PDF]

open access: yesClin Ophthalmol, 2020
Matthew Hirabayashi,1,2 Gurpal Virdi,1 Joshua King,1 Dayeong Lee,1 Van Nguyen,1,2 Jella An1,2 1School of Medicine, University of Missouri, Columbia, MO, USA; 2Mason Eye Institute, Department of Ophthalmology, University of Missouri, Columbia, MO ...
Hirabayashi M   +5 more
europepmc   +2 more sources

36-Month Outcomes of Standalone Kahook Dual Blade Goniotomy Compared with Ab-Interno Closed Conjunctiva Xen Gel Stent Implantation. [PDF]

open access: yesClin Ophthalmol
Nithya Boopathiraj,1 Isabella V Wagner,1 Paul Connor Lentz,2 Christian Draper,3 Chelsey Krambeer,1 Yazan S Abubaker,1 Bryan Chin Hou Ang,1,4,5 Darby D Miller,1 Syril Dorairaj1 1Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA; 2Department ...
Boopathiraj N   +8 more
europepmc   +2 more sources

Trabekulektomie ab interno mit dem Kahook Dual Blade – Klinische Erfahrungen

open access: yes, 2019
Hintergrund: Das Spektrum der minimalinvasiven Glaukomchirurgie (MIGS) erweitert sich in den letzten Jahren beständig. Im Bereich der Chirurgie des Trabekelmaschenwerkes ist ein neuer Ansatz die Exzision eines Streifens des Trabeculum corneosclerale mit einem doppelschneidigen Mikromesser.
Klabe, K   +5 more
  +8 more sources

Risk factors for severe bleeding complications in glaucoma surgery and the role of antiplatelet or anticoagulant agents [PDF]

open access: yes, 2022
PURPOSE: To evaluate the influences and risk factors for severe bleeding complications during glaucoma surgery, and to investigate the role of antiplatelet (AP) and anticoagulant (AC) agents.
Bahlmann, Dirk   +8 more
core   +1 more source

Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery [PDF]

open access: yes, 2022
The primary cause of failure for minimally invasive glaucoma surgery (MIGS) is fibrosis in the trabecular meshwork (TM) that regulates the outflow of aqueous humour, and no anti-fibrotic drug is available for intraocular use in MIGS.
Harashima, Hideyoshi   +9 more
core   +2 more sources

Clinical outcomes of the PAUL® glaucoma implant: One‐year results

open access: yesClinical &Experimental Ophthalmology, Volume 51, Issue 6, Page 566-576, August 2023., 2023
Abstract Background To report one‐year outcomes from a single‐centre cohort undergoing PAUL® Glaucoma Implant (PGI) surgery. Methods Retrospective review of patients undergoing PGI surgery at the University Eye Hospital Bonn, Germany, from April 2021 to September 2021. Results Forty‐five eyes of 41 patients were included. Qualified and complete success
Constance Weber   +6 more
wiley   +1 more source

Minimal-invasiv glaukomkirurgi (MIGS) for individer med glaukom. En metodevurdering [PDF]

open access: yes, 2021
Source at https://www.fhi.no/en/publ/2021/Minimally-Invasive-Glaucoma-Surgery-MIGS-for-individuals-with-glaucoma/Key messages: This health technology assessment (HTA) summarises and supplements a 2019 Canadian HTA on the effectiveness and safety of ...
Bidonde, Julia   +8 more
core   +6 more sources

Corneal Endothelial Cell Loss in Glaucoma and Glaucoma Surgery and the Utility of Management with Descemet Membrane Endothelial Keratoplasty (DMEK)

open access: yesJournal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
The corneal endothelium has a crucial role in maintaining a clear and healthy cornea. Corneal endothelial cell loss occurs naturally with age; however, a diagnosis of glaucoma and surgical intervention for glaucoma can exacerbate a decline in cell number and impairment in morphology. In glaucoma, the mechanisms for this are not well understood and this
Neeru A Vallabh   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy